Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Metabolic approaches: GLP-1 Incretins (semaglutide): appetite suppression | GLP-1/GIP incretins (tirzepatide): dual hormonal agonism | 5-Amino-1MQ: NNMT enzyme inhibition a non-hormonal mechanism, directly targeting lipid and NAD+ metabolism
It is not an approved therapy in most regions
Its a dosage calculator for peptides, this one will also work for Retatrutide but its a bit more generalised
HPLC/MS + endotoxin tested
no approved human use TGA Australia: approved as a compounded preparation (pharmacy compounding) Approximately 15+ peer-reviewed publications in PubMed Reference sources (PubMed) Ng FM
(3) Researchers have investigated whether NNMT inhibition might represent a novel approach to modulating energy expenditure and metabolic health
